Zurück zu den Rankings

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY)

Unterbewertet
Financial ServicesInsurance - ReinsuranceGermany

Fundamental

77

Kurs

$508.60

Marktkapitalisierung

$64.49B

Teil 1 · Was das Unternehmen wert ist

Übersicht

Munich Re takes on risk that other insurers do not want to carry alone. As a reinsurer, it agrees to cover a share of the claims a primary insurer might face from earthquakes, hurricanes, life and health claims and other large exposures, in exchange for a share of the premium. Through its ERGO subsidiary, it also sells insurance policies directly to households and businesses, mainly in Europe and Asia.

Wie das Geld verdient wird

Revenue is the premium collected for agreeing to take on risk, whether from another insurer (reinsurance) or directly from a policyholder (ERGO). Profit comes from two sources: an underwriting result, when premiums collected exceed claims paid and expenses, and investment income earned on the funds held between collecting a premium and eventually paying claims. Both depend on pricing risk accurately, which is the core skill of the business.

Umsatz nach Segment

Reinsurance64.1%

Property-casualty, life and health risk assumed from other insurers worldwide; the larger and more volatile of the two businesses.

ERGO (primary insurance)35.9%

Insurance policies sold directly to retail and commercial customers, mainly in Germany and other European and Asian markets.

Wettbewerbsvorteil

Skaleneffekte · Schmal

Underwriting catastrophe and life risk well requires decades of loss data, capital strong enough to survive a very bad year, and pricing discipline, which keeps the reinsurance market concentrated among a handful of large global players. The advantage is real but not exclusive: Swiss Re, Hannover Re and others compete on the same basis for the same large ceding companies.

Was die Nachfrage antreibt

Zyklisch

Reinsurance pricing moves in multi-year hard and soft cycles driven by recent loss experience rather than by GDP: after a run of large catastrophe losses, prices and terms harden industry-wide, and they soften again once capital rebuilds and competition returns.

Wichtigste Risiken

  • Natural catastrophe and climate risk — Insurance risk, mainly property-casualty underwriting risk, makes up around 60% of the group's regulatory capital requirement. Global natural-disaster losses reached about $224 billion in 2025, of which insurers covered roughly $108 billion, and Munich Re carries a direct share of that exposure.
  • Market risk on the investment portfolio — Premiums held between collection and claims payment are invested in bonds and other assets, so swings in interest rates and capital markets affect both investment income and the value of reserves held against future claims.
  • Credit and counterparty risk — The group is exposed to the risk that ceding companies, retrocessionaires or bond issuers in its investment portfolio fail to meet their obligations, one of the risk categories tracked under its Solvency II capital model.

Die Argumente dafür

Buyers argue that rising natural-catastrophe losses are pushing the whole reinsurance market toward firmer pricing and stricter terms, that Munich Re's scale and underwriting discipline let it selectively write the most attractively priced business, and that a fifth straight year of exceeding profit guidance shows the model working through the cycle.

Die Argumente dagegen

Sellers fear that climate change is making catastrophe losses larger and less predictable than historical models assume, that a prolonged period of soft pricing could follow the current hard market as competitors rebuild capital, and that a sharp move in interest rates could hurt the investment portfolio at the same time claims are rising.

Written by the editors, published on 18. August 2026

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 19. September 2026 with claude-haiku-4-5 — shared with all users

P/E: 10.7Score: 83Market cap: $16.52B

RGA is the direct rival of Munich Re's life and health reinsurance business, competing for mortality, morbidity and longevity treaties with the same life insurers.

Swiss Re Ltd (Schweizerische Rückversicherungs-Gesellschaft AG)SREN

Swiss Re is the other global full-line reinsurer of Munich Re's size, bidding for the same property-casualty and life reinsurance treaties with the same large primary insurers worldwide.

Hannover Rück SEHNR1

The other large German reinsurer competes with Munich Re on the same European and international treaty renewals, with a leaner cost structure aimed at the same cedants.

SCOR SESCR

The French group is the fourth European composite reinsurer, competing for the same property-casualty and life & health reinsurance programmes in Europe, Asia and the Americas.

Berkshire Hathaway Inc. (National Indemnity / Berkshire Hathaway Reinsurance Group)BRK.B

Berkshire's reinsurance arm writes the same large catastrophe and retroactive covers, and its balance-sheet capacity makes it the preferred alternative on the biggest single placements.

Everest Group, Ltd.EG

The Bermuda-based group competes on the same property-catastrophe and casualty treaty renewals in North America and internationally, alongside its own primary specialty book.

Bilanz & Liquidität

Umsatz

$63.95B

Letzte 12 Monate (bis 30.6.2026)

Nettogewinn

$6.87B

Letzte 12 Monate (bis 30.6.2026)

Freier Cashflow

$6.89B

Gesamtes Eigenkapital

$33.56B

Gesamtverbindlichkeiten

$8.22B

Current Ratio

0.28

Zinsdeckungsgrad

-

Schulden/EBITDA

-

Gewinn je Aktie

Umsatz & Nettogewinn

Freier Cashflow

Ertragsaufschlüsselung

Historische Aufstellung

Margen im Zeitverlauf

Verschuldung im Zeitverlauf

Wie schwer die Schulden wiegen

Wachstumsraster

Wachstum — Umsatz

Innerer-Wert-Schätzung

Allgemeiner FallUnterbewertet

Innerer Wert

$1579.56

Aktueller Kurs

$508.60

Sicherheitsmarge

+67.8%

Innerer-Wert-Spanne

$1026.72 - $2132.41

Streubreite zwischen den verwendeten Bewertungsmethoden, kein statistisch kalibriertes Konfidenzintervall.

Bewertungsmethoden

Kursziel der Analysten:$549.78
Diskontierter Cashflow (DCF):$2735.82
Gewinnmultiplikator (P/E):Nicht genügend Daten zur Berechnung
Graham-Wachstumsformel:$2767.05
Ertragskraftwert (EPV):$780.49
Gerechtfertigtes P/B:$1077.63
Dividendendiskontierung (Gordon):$523.87
P/FFO, Funds from Operations:Nicht genügend Daten zur Berechnung
Gewinn im Zyklusmittel:Nicht genügend Daten zur Berechnung
Umsatzmultiplikator:$1311.12
Analystenkonsens:Kaufen (14B / 10H / 4S)
Letzte Gewinnüberraschung:+20.15%

Bewertungskennzahlen

P/E-Verhältnis

9.53

ROE

21.3%

P/B-Verhältnis

1.92

P/FCF

9.36

Bruttomarge

35.4%

ROIC

20.2%

Rentabilitäts-Radar

Wertschöpfung (Wettbewerbsvorteil)

ROIC

20.2%

WACC

7.1%

ROIC − WACC

+13.1 pp

Der ROIC übersteigt die Kapitalkosten: Das Unternehmen schafft Wert für die Aktionäre.

Fundamentalanalyse-Kriterien

Bestanden (15)

  • Price CAGR 11.20%
  • ROIC 20.2%
  • Gross Margin 35.4%
  • P/FCF 9.36
  • P/B Ratio 1.92
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • CapEx intensity
  • DCF valuation (Undervalued)
  • ROE 20.6%
  • Analyst Consensus 50% Buy
  • Earnings Surprise avg 4.9%
  • PEG Ratio 0.23
  • Earnings Quality (OCF/NI) 1.08
  • Net Margin Trend 8.5% vs 7.8%

Nicht bestanden (3)

  • Current Ratio
  • Revenue Growth 5Y -0.2%
  • Piotroski F-Score 2/9

Nicht verfügbar (9)

  • EPS data insufficient
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Price below Graham Number
  • Share Dilution (missing shares data)

Piotroski F-Score

2/9

Ernsthafte finanzielle Bedenken

score
criteria

Gewinnqualität

1.08

Hohe Qualität: Gewinne durch Cashflow gedeckt

Aktienverwässerung

-

Aktienrückkäufe. Aktionärsfreundlich

Institutionelle Beteiligungen

Unternehmensführung

Führungsteam

NamePositionAlter
Dr. Christoph JureckaCEO & Chairman of Management Board51
Dr. Thomas BlunckMember of Management Board60
Dr. Markus RiessHead of Economics, Sustainability & Public Affairs and Member of Management Board59
Ms. Mari-Lizette MalherbeMember of Management Board-
Mr. Nicholas J. Gartside C.F.A.Chief Investment Officer & Member of Management Board50
Dr. Achim KassowChief Transformation Officer & Member of Management Board59
Mr. Stefan Heinrich GollingMember of Management Board & Labour Relations Director48
Ms. Clarisse KopffMember of Management Board-
Mr. Michael KernerMember of Management Board-
Mr. Andrew James BuchananCFO & Member of Management Board46

Prüfungsrisiko

2

Vorstandsrisiko

4

Vergütungsrisiko

2

Aktionärsrechterisiko

1

Teil 2 · Der Preis und der Einstiegszeitpunkt

Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.

Latest News

Recent headlines for MURGY, sourced from Markets Gazette.

No recent news for MURGY.